Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series

Head and Neck

Volumn 37, Issue 10, 2015, Pages 1403-1409

  Kress, Marie Adele S ^a   Sen, Neilayan ^a   Unger, Keith R ^a   Lominska, Christopher E ^b   Deeken, John F ^a   Davidson, Bruce J ^a   Newkirk, Kenneth A ^a   Hwang, Jimmy ^a   Harter, K William ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF KANSAS HOSPITAL   (United States)

Author keywords

CyberKnife; head and neck cancer; radiation oncology; reirradiation; stereotactic body radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN;

ACUTE TOXICITY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CHEMOTHERAPY; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONCURRENT CHEMOTHERAPY; CYBERKNIFE; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; INFECTION COMPLICATION; INTENTION TO TREAT ANALYSIS; LOCAL RECURRENCE FREE SURVIVAL; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MUCOSAL DISEASE; MUCOSAL TOXICITY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DERMATITIS; RADIATION INJURY; RADIATION NECROSIS; RADIOTHERAPY PLANNING SYSTEM; RETREATMENT; RETROSPECTIVE STUDY; SKIN ABSCESS; SKIN NECROSIS; SKIN ULCER; STEREOTACTIC BODY RADIATION THERAPY; TOXICITY; TREATMENT OUTCOME; WOUND COMPLICATION; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; MIDDLE AGED; MORTALITY; PROCEDURES; RADIATION DOSE FRACTIONATION; RADIOSURGERY; RE-IRRADIATION; SURVIVAL ANALYSIS; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOSURGERY; RE-IRRADIATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84941736723     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23763     Document Type: Article

References (29)

1. Pigott K, Dische S, Saunders MI,. Where exactly does failure occur after radiation in head and neck cancer? Radiother Oncol 1995; 37: 17-19.
2. Dawson LA, Anzai Y, Marsh L, et al., Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000; 46: 1117-1126.
3. Shakam A, Scrimger R, Liu D, et al., Dose-volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: a prospective multi-institutional trial. Radiother Oncol 2011; 99: 101-107.
4. Dragovic AF, Caudell JJ, Spencer SA, Carroll WR, Nabell LA, Bonner JA,. Locoregional failure and the risk of distant metastasis after modern radiotherapy for head and neck cancer. Head Neck 2013; 35: 381-387.
5. Beswick DM, Gooding WE, Johnson JT, Branstetter BF IV,. Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring. Laryngoscope 2012; 122: 1512-1517.
6. Mabanta SR, Mendenhall WM, Stringer SP, Cassisi NJ,. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 1999; 21: 591-594.
7. Chen AM, Phillips TL, Lee NY., Practical considerations in the re-irradiation of recurrent and second primary head-and-neck cancer: who, why, how: how much? Int J Radiat Oncol Biol Phys 2011; 81: 1211-1219.
8. Duprez F, Madani I, Bonte K, et al., Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiother Oncol 2009; 93: 563-569.
9. Sher DJ, Haddad RI, Norris CM Jr, et al., Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Cancer 2010; 116: 4761-4768.
10. Sulman EP, Schwartz DL, Le TT, et al., IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2009; 73: 399-409.
11. McDonald MW, Moore MG, Johnstone PA,. Risk of carotid blowout after reirradiation of the head and neck: a systematic review. Int J Radiat Oncol Biol Phys 2012; 82: 1083-1089.
12. Langer CJ, Harris J, Horwitz EM, et al., Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 2007; 25: 4800-4805.
13. Spencer SA, Harris J, Wheeler RH, et al., Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck 2008; 30: 281-288.
14. Roh KW, Jang JS, Kim MS, et al., Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2009; 74: 1348-1355.
15. Comet B, Kramar A, Faivre-Pierret M, et al., Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 2012; 84: 203-209.
16. Heron DE, Rwigema JC, Gibson MK, Burton SA, Quinn AE, Ferris RL,. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study. Am J Clin Oncol 2011; 34: 165-172.
17. Unger KR, Lominska CE, Deeken JF, et al., Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 77: 1411-1419.
18. Cengiz M, Özyiʇit G, Yazici G, et al., Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. Int J Radiat Oncol Biol Phys 2011; 81: 104-109.
19. Rwigema JC, Heron DE, Ferris RL, et al., The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy. Am J Clin Oncol 2011; 34: 372-379.
20. Eisenhauer EA, Therasse P, Bogaerts J, et al., New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.
21. Wang K, Heron DE, Clump DA, et al., Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation. Radiother Oncol 2013; 106: 90-95.
22. Benedict SH, Yenice KM, Followill D, et al., Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 2010; 37: 4078-4101.
23. American Cancer Society. Cancers linked to infectious diseases. Cancer Facts & Figures 2005 Special Section. Available at: http://www.cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/cancer-facts-figures-2005-special-section. Accessed January 3, 2013.
24. American Cancer Society. Cancer Facts & Figures 2012. Available at: http://pressroom.cancer.org/download/2012+cancer+facts+%26+figures.pdf. Acessed January 3, 2013.
25. Pignon JP, le Maître A, Maillard E, Bourhis J,; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
26. Jones AS, Bin Hanafi Z, Nadapalan V, Roland NJ, Kinsella A, Helliwell TR,. Do positive resection margins after ablative surgery for head and neck cancer adversely affect prognosis? A study of 352 patients with recurrent carcinoma following radiotherapy treated by salvage surgery. Br J Cancer 1996; 74: 128-132.
27. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000; 110 (3 Pt 2 Suppl 93): 1-18.
28. Wong LY, Wei WI, Lam LK, Yuen AP,. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 2003; 25: 953-959.
29. Kostrzewa JP, Lancaster WP, Iseli TA, Desmond RA, Carroll WR, Rosenthal EL,. Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. Laryngoscope 2010; 120: 267-272.